Actively Recruiting
Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy
Led by University Hospital Tuebingen · Updated on 2021-05-07
20
Participants Needed
1
Research Sites
334 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective assessment of Quality of Life in patients with locally recurrent breast cancer after close R0, R1 or R2 resection or local inoperability and hyperthermic radiotherapy.
CONDITIONS
Official Title
Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed local recurrence of breast cancer after close resection (≤1mm margin), R1 or R2 resection, or inoperable chest wall recurrence
- Female patients aged 18 years or older
- ECOG performance status of 0 to 2
- Estimated life expectancy greater than 2 years
- Provided informed consent
You will not qualify if you...
- Extensive distant metastases with an estimated life expectancy less than 2 years
- Severe heart disease including NYHA III/IV heart failure, recent myocardial infarction within 6 months, coronary heart disease, or third-degree AV block
- Presence of a cardiac pacemaker
- Second malignancy except certain controlled cancers (cervical carcinoma in situ, local basaliomas, superficial bladder carcinomas Ta, Tis, T1) treated curatively more than 5 years ago
- Pregnancy or breastfeeding
- Implanted port on the side treated with hyperthermia (contralateral side ports allowed)
- Subclavian vein thrombosis within the last 6 months
- Other conditions preventing hyperthermia treatment
- Conditions preventing regular follow-up care
- Organ transplant recipients
- Other implants on the ipsilateral chest wall
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tübingen, Department of Radiation Oncology
Tübingen, Baden-Wurttemberg, Germany, 72076
Actively Recruiting
Research Team
V
Vanessa Heinrich, MD
CONTACT
D
Daniel Zips, MD, Prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here